Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Mesh.i » - entrée « Antimalarials »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Antihypertensive Agents < Antimalarials < Antimetabolites  Facettes :

List of bibliographic references indexed by Antimalarials

Number of relevant bibliographic references: 211.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000326 (2021) C N Prashantha [Inde] ; K. Gouthami [Inde] ; L. Lavanya [Inde] ; Sivaramireddy Bhavanam [Inde] ; Ajay Jakhar [Inde] ; R G Shakthiraju [Inde] ; V. Suraj [Inde] ; K V Sahana [Inde] ; H S Sujana [Inde] ; N M Guruprasad [Inde] ; R. Ramachandra [Inde]Molecular screening of antimalarial, antiviral, anti-inflammatory and HIV protease inhibitors against spike glycoprotein of coronavirus.
000352 (2021) Nicolas De Schryver [Belgique] ; Nicolas Serck [Belgique] ; Marco Vinetti [Belgique] ; Ludovic Gérard [Belgique]Low-dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID-19: association does not mean causality.
000356 (2021) Mohamed O. Saad [Qatar]Letter to the editor about "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
000360 (2021) Sergey Moiseev [Oman] ; Sergey Avdeev [Russie] ; Michail Brovko [Russie] ; Pavel Novikov [Russie] ; Victor Fomin [Russie]Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?
000369 (2021) Philippe Colson [France] ; Bernard La Scola [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Didier Raoult [France]Interpretation of SARS-CoV-2 PCR results for the diagnosis of COVID-19.
000382 (2021) Michael Malaty [Australie] ; Tahrima Kayes [Australie] ; Anjalee T. Amarasekera [Australie] ; Matthew Kodsi [Australie] ; C Raina Macintyre [Australie] ; Timothy C. Tan [Australie]Incidence and treatment of arrhythmias secondary to coronavirus infection in humans: A systematic review.
000391 (2021) Yufeng Shang [République populaire de Chine] ; Tao Liu [République populaire de Chine] ; Jingfeng Li [République populaire de Chine] ; Natasha Mupeta Kaweme [République populaire de Chine] ; Xinghuan Wang [République populaire de Chine] ; Fuling Zhou [République populaire de Chine]Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus.
000398 (2021) Pankaj Bansal [États-Unis] ; Amandeep Goyal [États-Unis] ; Austin Cusick [États-Unis] ; Shubham Lahan [Inde] ; Harpal S. Dhaliwal [Inde] ; Poonam Bhyan [États-Unis] ; Pradnya Brijmohan Bhattad [États-Unis] ; Fawad Aslam [États-Unis] ; Sagar Ranka [États-Unis] ; Tarun Dalia [États-Unis] ; Lovely Chhabra [États-Unis] ; Devang Sanghavi [États-Unis] ; Bhavin Sonani [États-Unis] ; John M. Davis [États-Unis]Hydroxychloroquine: a comprehensive review and its controversial role in coronavirus disease 2019.
000405 (2021) Federico Diotallevi [Italie] ; Anna Campanati [Italie] ; Giulia Radi [Italie] ; Michele M. Luchetti [Italie] ; Devis Benfaremo [Italie] ; Corrado Tagliati [Italie] ; Oriana Simonetti [Italie] ; Annamaria Offidani [Italie]Hydroxychloroquine, dermatology, and SARS-CoV-2: Updating an old association.
000420 (2021) Boris Revollo [Espagne] ; Cristian Tebe [Espagne] ; Judith Pe Afiel [Espagne] ; Ignacio Blanco [Espagne] ; Nuria Perez-Alvarez [Espagne] ; Ruth Lopez [Espagne] ; Laura Rodriguez [Espagne] ; Josep Ferrer [Espagne] ; Pilar Ricart [Espagne] ; Enrique Moret [Espagne] ; Cristina Tural [Espagne] ; Anna Carreres [Espagne] ; Joan Matllo [Espagne] ; Sebastià Videla [Espagne] ; Bonaventura Clotet [Espagne] ; Josep M. Llibre [Espagne]Hydroxychloroquine pre-exposure prophylaxis for COVID-19 in healthcare workers.
000446 (2021) Massimo Nicol [Italie] ; Lorenzo Ferro Desideri [Italie] ; Matteo Bassetti [Italie] ; Carlo Enrico Traverso [Italie]Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak.
000448 (2021) Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Stéphane Honoré [France] ; Van Thuan Hoang [Viêt Nam] ; Philippe Colson [France] ; Didier Raoult [France]Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial revisited.
000467 (2021) Elena Beyzarov [États-Unis] ; Yan Chen [États-Unis] ; Rob Julg [États-Unis] ; Karen Naim [États-Unis] ; Jigna Shah [États-Unis] ; William W. Gregory [États-Unis] ; Ayman Ayoub [États-Unis] ; Patrick Caubel [États-Unis]Global Safety Database Summary of COVID-19-Related Drug Utilization-Safety Surveillance: A Sponsor's Perspective.
000469 (2021) I. Abadías-Granado [Espagne] ; A M Palma-Ruiz [Espagne] ; P A Cerro [Espagne] ; A M Morales-Callaghan [Espagne] ; M C G Mez-Mateo [Espagne] ; Y. Gilaberte [Espagne] ; R A Schwartz [États-Unis]Generalized pustular figurate erythema first report in two COVID-19 patients on hydroxychloroquine.
000472 (2021) Sameer Al-Abdi [Arabie saoudite] ; Maryam Al-Aamri [Arabie saoudite]G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost.
000477 (2021) Sarah El Mershati [France] ; Agathe Thouvenin [France] ; Philippe-Henri Secretan [France] ; Pascale De Lonlay [France] ; Caroline Tuchmann-Durand [France] ; Salvatore Cisternino [France] ; Joël Schlatter [France]Formulation and stability study of hydroxychloroquine sulfate oral suspensions.
000479 (2021) Carlos Gustavo Wambier [États-Unis]Focus on clinical outcomes of "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial".
000487 (2021) M. Ortega-Pe A [Chili] ; R. González-Cuevas [Chili]Familiar Dermatologic Drugs as Therapies for COVID-19.
000506 (2021) Barbara Burgos-Blasco [Espagne] ; Noemi Güemes-Villahoz [Espagne] ; Beatriz Vidal-Villegas [Espagne] ; Juan Donate-Lopez [Espagne] ; Julian Garcia-Feijoo [Espagne]Evaluation of retinotoxicity of COVID-19 treatment: Hydroxychloroquine and lopinavir/ritonavir.
000509 (2021) Raúl Rigo-Bonnin [Espagne] ; Francesca Canalias [Espagne]Estimation of the uncertainty of values assigned to calibration materials prepared in-house: An example for hydroxychloroquine calibrators in blood-hemolysate-based matrix.
000516 (2021) Yi Su [République populaire de Chine] ; Yun Ling [République populaire de Chine] ; Yuyan Ma [République populaire de Chine] ; Lili Tao [États-Unis] ; Qing Miao [République populaire de Chine] ; Qingfeng Shi [République populaire de Chine] ; Jue Pan [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine] ; Bijie Hu [République populaire de Chine]Efficacy of early hydroxychloroquine treatment in preventing COVID-19 pneumonia aggravation, the experience from Shanghai, China.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Antimalarials" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Antimalarials" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Antimalarials
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021